GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Oriental Bioengineering Inc (OTCPK:AOBI) » Definitions » Cyclically Adjusted Price-to-FCF

American Oriental Bioengineering (American Oriental Bioengineering) Cyclically Adjusted Price-to-FCF : (As of Jun. 25, 2024)


View and export this data going back to 1991. Start your Free Trial

What is American Oriental Bioengineering Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


American Oriental Bioengineering Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for American Oriental Bioengineering's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oriental Bioengineering Cyclically Adjusted Price-to-FCF Chart

American Oriental Bioengineering Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

American Oriental Bioengineering Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of American Oriental Bioengineering's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, American Oriental Bioengineering's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Oriental Bioengineering's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Oriental Bioengineering's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where American Oriental Bioengineering's Cyclically Adjusted Price-to-FCF falls into.



American Oriental Bioengineering Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

American Oriental Bioengineering's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2013 is calculated as:

For example, American Oriental Bioengineering's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2013 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2013 (Change)*Current CPI (Sep. 2013)
=-421.877/97.3319*97.3319
=-421.877

Current CPI (Sep. 2013) = 97.3319.

American Oriental Bioengineering Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200312 26.122 72.808 34.921
200403 79.030 73.682 104.396
200406 -18.364 73.459 -24.332
200409 83.941 74.637 109.465
200412 41.417 74.488 54.119
200503 28.930 75.597 37.248
200506 14.429 74.618 18.821
200509 30.795 75.290 39.810
200512 45.765 75.666 58.869
200603 56.262 76.340 71.733
200606 71.873 76.034 92.006
200609 60.603 76.413 77.194
200612 199.646 77.793 249.790
200703 49.727 78.884 61.356
200706 170.985 79.357 209.713
200709 139.240 81.276 166.748
200712 206.474 82.911 242.387
200803 134.603 85.485 153.257
200806 220.051 85.058 251.806
200809 -176.612 85.057 -202.099
200812 -1,270.391 83.956 -1,472.797
200903 36.023 84.457 41.514
200906 245.787 83.615 286.108
200909 126.910 84.369 146.409
200912 -241.600 85.386 -275.401
201003 52.506 86.316 59.207
201006 22.395 85.886 25.379
201009 -57.855 87.267 -64.527
201012 -0.408 89.289 -0.445
201103 208.145 91.154 222.252
201106 -163.632 91.612 -173.848
201109 106.237 92.711 111.532
201112 -418.360 92.885 -438.387
201203 -336.494 94.367 -347.067
201206 -247.256 93.495 -257.402
201209 -54.237 94.482 -55.873
201212 -305.486 95.237 -312.207
201303 -30.288 96.372 -30.590
201306 -55.329 95.984 -56.106
201309 -421.877 97.332 -421.877

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


American Oriental Bioengineering  (OTCPK:AOBI) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


American Oriental Bioengineering Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of American Oriental Bioengineering's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


American Oriental Bioengineering (American Oriental Bioengineering) Business Description

Traded in Other Exchanges
N/A
Address
1 Liangshuihe First Ave, Beijing E-Town, Economic and Technology Development Area, E-Town, Beijing, CHN, 100176
Website
American Oriental Bioengineering Inc is a manufacturer of pharmaceutical and healthcare products. Its product line encompasses prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products.
Executives
Patti Cosimo J director AMERICAN ORIENTAL BIOENGINEERING, INC. 90 PARK AVENUE, 17TH FLOOR NEW YORK NY 10016

American Oriental Bioengineering (American Oriental Bioengineering) Headlines

No Headlines